Dipeptidyl peptidase 4 inhibitors, sodium glucose cotransporter 2 inhibitors, and glucagon-like peptide 1 receptor agonists do not worsen diabetic macular edema.
Alexander PhuMark BanghartMozhdeh BahrainianT Y Alvin LiuRisa M WolfRoomasa ChannaPublished in: Journal of diabetes and its complications (2024)
We did not find an association between DPP-4i, SGLT2-i, or GLP-1 receptor agonist use and increased hazard of development of DME among patients with DR.
Keyphrases